When a German industrial giant like Merck KGaA drops $11.3 billion on a medtech acquisition, it’s not just a headline for healthcare investors—it’s a signal about where big money sees safety. Right now, that’s not crypto. While Bitcoin has inched up 2.4% to $60,264 and Ethereum gained 3% to $1,584, the broader market is still drowning in “Extreme Fear” (Fear & Greed at 15). That’s the same sentiment that often precedes capitulation—or a contrarian bounce. But Merck’s move suggests institutional capital is betting on tangible, regulated assets, not digital ones.
For retail crypto holders, this buyout matters because it reflects a broader risk-off mood. The same week, US senators urged the CFTC to probe Polymarket over “deceptive marketing,” and Strategy’s Bitcoin bet is showing a $14 billion loss. These aren’t isolated events—they’re part of a pattern where traditional finance is pulling back from crypto exposure. Merck’s deal is a reminder that when fear is this high, deep-pocketed players double down on what they can touch, not what they can tokenize.
What to watch next: If the Fear & Greed Index stays below 20 for another week, we could see a flight from altcoins into stablecoins or even out of crypto entirely. Meanwhile, Kraken’s xStocks opening IPO registration for Bending Spoons to EEA retail is a rare bright spot—it